Amyris, Inc. (AMRS) Stock Analysis

Amyris, Inc. (AMRS) Materials & Commodity Exposure

Amyris, Inc. is a synthetic biotechnology company specializing in clean health and beauty, and flavors and fragrance markets. It distinguishes itself through the development and sale of sustainable ingredients and consumer products under brands like Biossance and Purecane, targeting environmentally conscious consumers and industries seeking sustainable alternatives.

What Is the Investment Thesis for AMRS?

Amyris presents a compelling investment thesis centered on its innovative synthetic biotechnology platform and expanding portfolio of sustainable consumer brands. The company's focus on clean beauty, personal care, and flavors and fragrances aligns with growing consumer demand for sustainable and ethically sourced products. Key value drivers include the expansion of its existing brands, the launch of new products, and the increasing adoption of its ingredients by other companies. However, Amyris operates in a competitive landscape and faces challenges related to scaling production, managing costs, and achieving profitability. The company's negative profit margin of -198.6% highlights the need for improved financial performance. Successful execution of its growth strategy and efficient management of its operations are crucial for realizing the company's long-term potential.

Based on FMP financials and quantitative analysis

AMRS Key Highlights

Operates in the clean health and beauty, and flavors and fragrance markets, aligning with growing consumer demand for sustainable products.

• Offers a diverse portfolio of consumer brands, including Biossance, Pipette, and Purecane, targeting different segments of the sustainable products market.
• Supplies ingredients to other companies in the flavor and fragrance, nutrition, and cosmetics industries, providing a diversified revenue stream.
• Gross margin of 4.1% indicates potential for improvement through increased efficiency and economies of scale.
• Collaboration agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine represents a potential growth opportunity in the healthcare sector.

Who Are AMRS's Competitors?

AMRS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are AMRS's Key Strengths?

Innovative synthetic biotechnology platform.

• Strong portfolio of consumer brands.
• Focus on sustainable and ethically sourced ingredients.
• Vertically integrated operations.

What Are AMRS's Weaknesses?

Negative profit margin.

• High operating expenses.
• Reliance on a limited number of key ingredients.
• Relatively small market share compared to larger competitors.

What Could Drive AMRS Stock Higher?

Launch of new products under existing brands.

• Expansion of distribution channels for consumer products.
• Increasing adoption of Amyris's ingredients by other companies.
• Strategic partnerships and collaborations to expand market reach.

What Are the Key Risks for AMRS?

Financial-distress signal — its Altman Z-Score of -9.08 sits in the distress zone (elevated bankruptcy risk).

• Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
• Fluctuations in raw material prices.
• Changes in consumer preferences.
• Regulatory changes affecting the biotechnology industry.
• Competition from larger and more established companies.
• Negative profit margin and high operating expenses.

What Are the Growth Opportunities for AMRS?

• Expansion of Existing Brands: Amyris has the opportunity to expand its existing brands, such as Biossance and Purecane, through new product launches, increased distribution, and targeted marketing campaigns.
• New Product Development: Amyris can leverage its synthetic biotechnology platform to develop new and innovative ingredients and products for various markets. The company's expertise in engineering microorganisms allows it to create sustainable alternatives to traditional ingredients, addressing the growing demand for eco-friendly solutions in the flavor and fragrance, nutrition, and cosmetics industries.
• Strategic Partnerships and Collaborations: Amyris can pursue strategic partnerships and collaborations with other companies to expand its reach and access new markets. Collaborating with established players in the consumer goods, food and beverage, and cosmetics industries can accelerate the adoption of Amyris's ingredients and products.
• Geographic Expansion: Amyris has the opportunity to expand its geographic presence, particularly in Asia and South America, where demand for sustainable products is growing rapidly. Establishing distribution networks and partnerships in these regions can drive significant revenue growth.
• Increased Adoption of Sustainable Ingredients: Amyris can capitalize on the increasing demand for sustainable ingredients by expanding its supply agreements with other companies. As more companies commit to reducing their environmental footprint, the demand for Amyris's bio-based ingredients is expected to increase.

What Are AMRS's Competitive Advantages?

• Proprietary synthetic biotechnology platform for developing sustainable ingredients.
• Established brands with a loyal customer base in the clean beauty and personal care markets.
• Strong relationships with ingredient customers in various industries.
• Vertically integrated operations, from ingredient development to product manufacturing and distribution.

What Does AMRS Do?

Amyris, Inc., founded in 2003 and headquartered in Emeryville, California, is a synthetic biotechnology company focused on creating sustainable ingredients for various markets. Originally named Amyris Biotechnologies, Inc., the company rebranded in 2010 to reflect its expanding focus. Amyris utilizes synthetic biology to engineer microorganisms that convert plant-based sugars into high-value ingredients. These ingredients are then used in a range of products, including clean beauty, personal care, health and wellness consumer products, as well as ingredients for the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. Amyris's portfolio includes a diverse range of brands such as Biossance (clean beauty), Pipette (baby care), Purecane (zero-calorie sweetener), Terasana (skincare), Costa Brazil (sustainable beauty), OLIKA (hand sanitizers), Rose Inc. (color cosmetics), and JVN (haircare). These brands cater to the growing demand for sustainable and ethically sourced products. In addition to its consumer brands, Amyris also supplies ingredients to other companies in the flavor and fragrance, nutrition, and cosmetics industries. Amyris also has a collaboration agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine.

What Products and Services Does AMRS Offer?

• Develops and manufactures sustainable ingredients using synthetic biotechnology.
• Sells clean beauty, personal care, and health and wellness consumer products.
• Offers ingredients to the flavor and fragrance industry.
• Provides ingredients for the nutrition, food, and beverage markets.
• Markets products under brands like Biossance, Pipette, and Purecane.
• Collaborates on the development of a COVID-19 vaccine.

How Does AMRS Make Money?

• Develops and manufactures sustainable ingredients through synthetic biology.
• Sells finished consumer products directly to consumers through e-commerce and retail channels.
• Supplies ingredients to other companies in the flavor and fragrance, nutrition, and cosmetics industries.
• Generates revenue through product sales and ingredient supply agreements.

What Industry Does AMRS Operate In?

Amyris operates within the specialty chemicals industry, which is experiencing increasing demand for sustainable and bio-based alternatives. The global market for specialty chemicals is estimated to be worth hundreds of billions of dollars, with a growing segment focused on green and sustainable solutions. Amyris competes with both traditional chemical companies and other synthetic biotechnology firms. The company's focus on clean beauty and personal care positions it within a rapidly expanding market segment driven by increasing consumer awareness of environmental and health issues.

Who Are AMRS's Key Customers?

• Consumers seeking clean beauty, personal care, and health and wellness products.
• Companies in the flavor and fragrance industry looking for sustainable ingredients.
• Businesses in the nutrition, food, and beverage markets seeking bio-based alternatives.
• Other cosmetics companies utilizing Amyris's ingredients in their products.

Amyris, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -9.08 places it in the distress zone, a signal of elevated financial risk.

Return on equity for Amyris, Inc. stands at 461.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -65.0%, showing how much profit it generates from its asset base. A current ratio of 0.79 means current liabilities exceed short-term assets, a liquidity point worth watching.

Company Profile

Amyris, Inc. operates in the Chemicals - Specialty industry within the Basic Materials sector. It is headquartered in EmeryVille, US. The company is led by CEO Hermanus Kieftenbeld. AMRS has traded publicly since 2010.

AMRS Financials

AMRS Latest News

No recent news available for AMRS.

What Investors Ask About Amyris, Inc. (AMRS) — Basic Materials

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources